These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9155023)

  • 1. Positive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues.
    Luo K; Lodish HF
    EMBO J; 1997 Apr; 16(8):1970-81. PubMed ID: 9155023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.
    Luo K; Lodish HF
    EMBO J; 1996 Sep; 15(17):4485-96. PubMed ID: 8887540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
    Feng XH; Derynck R
    EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
    Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C
    J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.
    Rechtman MM; Nakaryakov A; Shapira KE; Ehrlich M; Henis YI
    J Biol Chem; 2009 Mar; 284(12):7843-52. PubMed ID: 19147499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma.
    Knaus PI; Lindemann D; DeCoteau JF; Perlman R; Yankelev H; Hille M; Kadin ME; Lodish HF
    Mol Cell Biol; 1996 Jul; 16(7):3480-9. PubMed ID: 8668164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
    Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
    J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
    Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
    Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells.
    Wells RG; Gilboa L; Sun Y; Liu X; Henis YI; Lodish HF
    J Biol Chem; 1999 Feb; 274(9):5716-22. PubMed ID: 10026191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation.
    Zhu HJ; Sizeland AM
    J Biol Chem; 1999 Apr; 274(17):11773-81. PubMed ID: 10206994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X; Bellis S; Yan Z; Friedman E
    Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslational Modifications of TGF-β Receptors.
    Yan X; Chen YG
    Methods Mol Biol; 2016; 1344():49-61. PubMed ID: 26520117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta (TGF-beta1) activates TAK1 via TAB1-mediated autophosphorylation, independent of TGF-beta receptor kinase activity in mesangial cells.
    Kim SI; Kwak JH; Na HJ; Kim JK; Ding Y; Choi ME
    J Biol Chem; 2009 Aug; 284(33):22285-22296. PubMed ID: 19556242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.
    Tazat K; Hector-Greene M; Blobe GC; Henis YI
    Mol Biol Cell; 2015 Oct; 26(19):3535-45. PubMed ID: 26269580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GS domain of the transforming growth factor-beta type I receptor is important in signal transduction.
    Franzén P; Heldin CH; Miyazono K
    Biochem Biophys Res Commun; 1995 Feb; 207(2):682-9. PubMed ID: 7864860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.
    Chen X; Wang H; Liao HJ; Hu W; Gewin L; Mernaugh G; Zhang S; Zhang ZY; Vega-Montoto L; Vanacore RM; Fässler R; Zent R; Pozzi A
    J Clin Invest; 2014 Aug; 124(8):3295-310. PubMed ID: 24983314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II.
    McLean S; Di Guglielmo GM
    Biochem J; 2010 Jul; 429(1):137-45. PubMed ID: 20406198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta.
    Saitoh M; Nishitoh H; Amagasa T; Miyazono K; Takagi M; Ichijo H
    J Biol Chem; 1996 Feb; 271(5):2769-75. PubMed ID: 8576253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
    Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
    Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.